Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.

Few patients are using the apps hospitals offer

Despite a large selection of hospital-offered apps, just 2 percent of patients are using them, according to a report from Accenture. 

Thumbnail

Boston Children's Hospital offers 9 innovations to watch in 2016

Clinical, digital and business leaders from around Boston Children’s Hospital offered their forecasts for the science and clinical innovations that will have the biggest impact on healthcare in 2016.

Healthcare innovation requires curiosity

Curiosity is a critical yet underrated skill for 21st century healthcare innovation, according to a post on the HL7 blog authored by a writer known as HealthIsCool.

Fifth annual med adherence challenge begins this month

The fifth annual Medication Adherence Team Challenge begins on January 19.

CMS announces initiative to address health-related social needs

The Centers for Medicare and Medicaid Services (CMS) recently announced a initiative that may help some health systems address patients’ health-related social needs.

Thumbnail

Demand on the rise for EMR-dedicated scribes

The Affordable Care Act is swelling patient rolls while CMS continues slapping EMR-resistant providers with increasingly hefty financial penalties. What’s an already overburdened doctor to do? 

3 of the healthcare products unveiled at CES 2016

The Consumer Electronics Show kicked off this week and the first few announcements indicate some exciting innovations. 

iPhone, Google help doctor perform lifesaving surgery

Redmond Burke, MD, used an iPhone and Google Cardboard, a virtual reality tool, to successfully operate on a baby girl previously dismissed as impossible to save.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.